Corneal collagen cross-linking (CXL) is a procedure that uses riboflavin eye drops and UV light to strengthen the cornea. The technique was first developed in 1997 in Germany. CXL uses a photosensitizer like riboflavin, a UV light source, and the resulting photochemical reaction to cross-link collagen in the cornea. The standard Dresden protocol involves debriding the corneal epithelium, applying riboflavin drops every 5 minutes for 30 minutes under UV light exposure, also applying drops during exposure. After CXL, antibiotics and soft contact lenses are applied. Common side effects are haziness, punctate keratitis, striae, and eye pain.